Press Releases

Date	Title and Summary	Additional Formats
Toggle Summary May 10, 2011	EDAP Schedules Webcast and Conference Call of First Quarter 2011 Results LYON, France , May 10, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its first quarter 2011 results announcement, which will take place on Tuesday, May 24, 2011 , before the opening of the market.	View HTML EDAP Schedules Webcast and Conference Call of First Quarter 2011 Results 14.6 KB
Toggle Summary May 09, 2011	Published 15-Year Clinical Review Supports EDAP's Ablatherm(R) HIFU as Viable Primary Treatment for Local Prostate Cancer at Any Stage Study to Appear in June 2011 Current Urology Report	View HTML Published 15-Year Clinical Review Supports EDAP's Ablatherm(R) HIFU as Viable Primary Treatment for Local Prostate Cancer at Any Stage 17.9 KB
Toggle Summary Apr 20, 2011	EDAP Highlights Innovative Sonolith i-move Lithotripter at the Annual Japanese Urological Association Meeting EDAP Pursues Lithotripsy Expansion Strategy	View HTML EDAP Highlights Innovative Sonolith i-move Lithotripter at the Annual Japanese Urological Association Meeting 15.1 KB
Toggle Summary Apr 14, 2011	EDAP and Collaboration Partners Awarded EUR 1.1 Million European Grant for HIFU Triggered Drug Delivery Program Technology Focuses on Facilitating Ultrasound Assisted Drug Delivery	View HTML EDAP and Collaboration Partners Awarded EUR 1.1 Million European Grant for HIFU Triggered Drug Delivery Program 17.9 KB
Toggle Summary Mar 29, 2011	EDAP Reports Fourth Quarter and Full Year 2010 Financial Results 2010 Highlights U.S. ENLIGHT Ablatherm-HIFU clinical trial completed enrollment in June 2010 and entered two year follow-up phase Lithotripsy division revenues increased 10.2% year-over-year to EUR 16.8 million ( USD 22.2 million ), fueled by innovative lithotripter product line Outstanding	View HTML EDAP Reports Fourth Quarter and Full Year 2010 Financial Results 40.2 KB
Toggle Summary Mar 28, 2011	EDAP to Exclusively Distribute Medical Measurement Systems Urodynamic Products in Japan Validates EDAP's Leadership in Urodynamics on the Territory	View HTML EDAP to Exclusively Distribute Medical Measurement Systems Urodynamic Products in Japan 14.8 KB
Toggle Summary Mar 25, 2011	EDAP Receives Strong Reception at European Association of Urology Annual Conference Confirmation of HIFU Position in Expanding Focal Therapy Trend in Prostate Cancer Strong Recognition of EDAP's Expertise in Lithotripsy Innovation LYON, France , March 25, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, reported today positive	View HTML EDAP Receives Strong Reception at European Association of Urology Annual Conference 15.8 KB
Toggle Summary Mar 03, 2011	EDAP Schedules Webcast and Conference Call for Fourth Quarter and Full Year 2010 Results LYON, France , March 3, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the details relating to its fourth quarter and full year 2010 results announcement, which will take place on Tuesday, March 29, 2011 , before the opening of the	View HTML EDAP Schedules Webcast and Conference Call for Fourth Quarter and Full Year 2010 Results 13.1 KB
Toggle Summary Feb 08, 2011	EDAP Expands Into Caribbean Region Installs Ablatherm-HIFU in Dominican Republic	View HTML EDAP Expands Into Caribbean Region 16.4 KB
Toggle Summary Feb 02, 2011	EDAP Granted Special Temporary Reimbursement for Ablatherm-HIFU in France LYON, France , Feb. 2, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today it has been granted a special temporary reimbursement for Ablatherm-HIFU for the treatment of localized prostate cancer by the French National Authority for Health	View HTML EDAP Granted Special Temporary Reimbursement for Ablatherm-HIFU in France 13.8 KB